3 Days skin puncture free? Yes, it is possible
i-Port Advance™ is a small injection port that lets you take your injectable medications without having to puncture your skin for each injection. It’s easy to wear and easy to use. The port can be worn for up to three days* during all normal activities, including sleeping, bathing and exercise.
Simple to apply and easy to use
Application is quick and virtually pain free with the built-in serter. Only change the i-Port Advance™ injection port every three days.
“Now we are less scared of injecting ourselves”
Those newly diagnosed with type 1 diabetes who might be afraid of injections. Anyone who experiences the emotional challenges of injections like fear, anxiety and stress or their physical impact like bruising, scaring or pain may benefit from i-Port Advance™. It’s especially beneficial to children and their loved ones, who often get anxiety when it’s time to take an injection. It can also help in administering additional doses (for example correction boluses and injections to cover snacks between meals). Children or teenagers may also benefit from i-Port Advance™ as an aid to help them become more independent when administering insulin therapy. If you have type 2 diabetes and are new to taking insulin, this is a great way to improve the transition to taking injections.
You can use the port with pens or syringes. Needles need to be 5-8mm (3/16-5/16”) in length and 32-28 gauge.
You can use both, but there is a rule: Always inject rapid acting insulin first, wait one hour, then inject your long acting insulin.
You can watch the Training Video below and download the User Guide
* Do not inject more than 75 times through a single device. - Product CE marked by Unomedical a/s. - This information does not substitute the Instructions for Use/User Guide - For a listing of indications, contraindications, precautions, warnings, and potential adverse events, please refer to the Instructions for Use
1. Hanas 2013 [Hanas R. I-Port indwelling catheter alleviates injection pain in children with Diabetes. Pediatr Diabetes. 2013; 14 (Suppl. 18): 114].
2. Data on file; survey conducted in 2015 in the US
3. Riley D, Raup G. Impact of a subcutaneous injection device on improving patient care. Nurs Manage. 2010;41(6):49–50